Pages that link to "Q37269716"
Jump to navigation
Jump to search
The following pages link to UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer (Q37269716):
Displaying 50 items.
- The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein (Q24297944) (← links)
- NIRF/UHRF2 occupies a central position in the cell cycle network and allows coupling with the epigenetic landscape (Q26851503) (← links)
- The PHD Finger of Human UHRF1 Reveals a New Subgroup of Unmethylated Histone H3 Tail Readers (Q27675643) (← links)
- DNA methylation, its mediators and genome integrity (Q28080760) (← links)
- MBD4 interacts with and recruits USP7 to heterochromatic foci (Q28250621) (← links)
- Overexpression of UHRF1 gene correlates with the major clinicopathological parameters in urinary bladder cancer (Q33692622) (← links)
- Urine collection and processing for protein biomarker discovery and quantification (Q33780855) (← links)
- UHRF1 is a novel diagnostic marker of lung cancer. (Q34005854) (← links)
- Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1. (Q34278046) (← links)
- Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties (Q34989248) (← links)
- Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1 (Q35166305) (← links)
- Analysis of UHRF1 expression in human ovarian cancer tissues and its regulation in cancer cell growth (Q35662659) (← links)
- An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer (Q35848254) (← links)
- Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell proliferation and apoptosis (Q35904200) (← links)
- UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation (Q36211327) (← links)
- E2F8 as a Novel Therapeutic Target for Lung Cancer (Q36294944) (← links)
- UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis (Q36536562) (← links)
- Long noncoding RNA UPAT promotes colon tumorigenesis by inhibiting degradation of UHRF1. (Q36563349) (← links)
- The prognostic value of UHRF-1 and p53 in gastric cancer (Q36606770) (← links)
- Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer (Q36848353) (← links)
- Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1). (Q37000550) (← links)
- Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT). (Q37076868) (← links)
- UHRF1 gene silencing inhibits cell proliferation and promotes cell apoptosis in human cervical squamous cell carcinoma CaSki cells (Q37105752) (← links)
- Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness (Q37317582) (← links)
- UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma (Q37628934) (← links)
- Zebrafish Discoveries in Cancer Epigenetics. (Q37651410) (← links)
- Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma (Q37705867) (← links)
- Significant cancer prevention factor extraction: an association rule discovery approach. (Q37779500) (← links)
- Approaches to Target the Genome and Its Epigenome in Cancer (Q37855866) (← links)
- Prospects for Epigenetic Compounds in the Treatment of Autoimmune Disease (Q37882668) (← links)
- Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma (Q38313414) (← links)
- MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1. (Q38840573) (← links)
- Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines? (Q38944664) (← links)
- Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain 1 promotes bladder cancer progression (Q38947074) (← links)
- Diagnostic and prognostic value of plasma and tissue ubiquitin-like, containing PHD and RING finger domains 1 in breast cancer patients (Q39252224) (← links)
- The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer. (Q39304639) (← links)
- The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression (Q39397231) (← links)
- UHRF1 confers radioresistance to human breast cancer cells (Q39633641) (← links)
- Analysis of the UHRF1 expression in serum and tissue for gastric cancer detection (Q40751381) (← links)
- Critical role of lysine 134 methylation on histone H2AX for γ-H2AX production and DNA repair. (Q42935227) (← links)
- UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer (Q43945307) (← links)
- Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy (Q47130735) (← links)
- UHRF1 is an Independent Prognostic Factor and a Potential Therapeutic Target of Esophageal Squamous Cell Carcinoma (Q47301297) (← links)
- UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells (Q47383014) (← links)
- Uhrf1 is indispensable for normal limb growth by regulating chondrocyte differentiation through specific gene expression. (Q48228570) (← links)
- The correlation between miR-146a C/G polymorphism and UHRF1 gene expression level in gastric tumor. (Q53170052) (← links)
- Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma. (Q54244821) (← links)
- UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer. (Q54330859) (← links)
- Modulation of Gene Expression and Cell-Cycle Signaling Pathways by the EGFR Inhibitor Gefitinib (Iressa) in Rat Urinary Bladder Cancer (Q54344732) (← links)
- Upregulation of UHRF1 promotes the progression of melanoma by inducing cell proliferation. (Q54967792) (← links)